Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
Z.-J. Chen et al.
Journal of Hazardous Materials 412 (2021) 125241
2. Materials and methods
J = 5.7 Hz, 1 H), 7.00 (d, J = 7.2 Hz, 1 H), 6.84 (d, J = 8.0 Hz, 1 H),
6.74 (t, J = 7.7 Hz, 1 H), 3.01 (m, 4 H), 2.50 (d, J = 1.5 Hz, 3 H), 2.20
(t, J = 7.4 Hz, 2 H), 1.50 (m, 13 H), 1.43 (dd, J = 14.8, 7.3 Hz, 2 H),
1.39 (s, 6 H), 1.30 (dd, J = 15.2, 8.0 Hz, 2 H).
2.1. Reagents and animals
Standards of carbofuran, isoprocarb, carbaryl, carbofuran-3-
hydroxy, carbosulfan, benfuracarb, metolcarb and fenobucarb were
supplied by TMRM Co. Ltd. (Beijing, China). Benzofuranol, 2-isopropyl-
phenol, 1-naphthol, ethyl bromoacetate, ethyl 4-bromobutyrate, 4-
nitrophenyl chloroformate, 6-aminocaproic acid and 1-naphthoxyacetic
acid were purchased from Heowns Biochemical Technology Co., Ltd.
2.3.2. Hapten-B, 2-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)oxy)acetic
acid
Benzofuranol (3.2 g, 20 mmol) and K2CO3 (2 g) were added to 10 mL
DMF and stirred at 70 ◦C. Ethyl bromoacetate (4.5 mL, 40 mmol) was
then added to the mixture, which was stirred at 70 ◦C for 6 h. After the
reaction was completed, the mixture was added to ethyl acetate and
washed with brine to remove K2CO3 and DMF. The organic phase was
evaporated, and an LiOH solution (1.6 g, 10 mL) was added to the
resulting mixture. The mixture was stirred for 1 h. The aqueous phase
was washed with ethyl acetate three times to remove the unhydrolyzed
product, and HCl was used to adjust the pH of the mixture to 4–5. The
crude product was subsequently extracted by ethyl acetate. Ethyl acetate
was then evaporated to obtain the final product. The following results
were obtained from the ESI-MS analysis (negative): m/z 221 [M-H]-; 1H
NMR (600 MHz, CD2Cl2) δ 9.61 (d, J = 7.0 Hz, 1 H), 9.51 (m, 2 H),
7.45 (s, 2 H), 5.82 (s, 2 H), 4.23 (s, 6 H).
(Tianjin,
China).
N-hydroxysuccinimide
(NHS),
1-(3-
dimethylaminopropyl)ꢀ 3-ethylcarbodiimide hydrochloride (EDC), and
3,3′,5,5′-tetramethylbenzidine (TMB) were obtained from Aladdin
Chemical Technology Co., Ltd. (Shanghai, China). Lactoferrin (LF) was
obtained from FUJIFILM Wako Pure Chemical Co. Ltd. (Japan). Bovine
serum albumin (BSA), keyhole limpet hemocyanin (KLH), complete and
incomplete Freund’s adjuvants, and polyethylene glycol solution
(Hybri-Max™) were obtained from Sigma-Aldrich (Shanghai, China).
Protein G resin and a secondary antibody (goat anti-mouse IgG, HRP
conjugated) were obtained from TransGen Biotech Co. Ltd. (Beijing,
China). Ninety-six-well polystyrene microplates were obtained from
Shenzhen Jincanhua Industry Co. Ltd. (Shenzhen, China). N,N-
dimethylformamide (DMF), dichloromethane (DCM), triethylamine
(TEA), Tween-20, methanol (MeOH), 1,4-dioxane, and petroleum ether
were obtained from Damao Chemical Reagent Co., Ltd. (Tianjin, China).
Gold nanoparticles (GNPs) were obtained from Wanlian Biotechnologies
Co. Ltd. (Guangzhou, China).
2.3.3. Hapten-C, 4-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)oxy)
butanoic acid
The same synthesis procedure was used for hapten-C as for hapten-B,
except ethyl bromoacetate was replaced by ethyl 4-bromobutyrate. The
following results were obtained from the ESI-MS analysis (negative): m/
z 249 [M-H]-; 1H NMR (600 MHz, CD2Cl2) δ 6.80 (dd, J = 6.1, 2.5 Hz,
1 H), 6.76 (dd, J = 9.0, 5.2 Hz, 2 H), 4.08 (t, J = 6.2 Hz, 2 H), 3.04 (s,
2 H), 2.60 (t, J = 7.3 Hz, 2 H), 2.12 (dd, J = 13.6, 6.6 Hz, 2 H), 1.49
(s, 6 H).
BALB/c female mice were purchased from the Guangdong Medical
Experimental Animal Centre and raised at the Animal Experiment
Centre of South China Agriculture University (Animal Experiment
Ethical Approval Number: 2019054, Fig. S1).
2.3.4. Hapten-D, 6-(((2-isopropylphenoxy)carbonyl)amino)hexanoic acid
The same synthesis procedure was used for hapten-D as for hapten-A,
except benzofuranol was replaced by 2-isopropylphenol. The following
results were obtained from the ESI-MS analysis (negative): m/z 292 [M-
H]-; 1H NMR (600 MHz, MeOD) δ 7.32 (dd, J = 5.8, 3.5 Hz, 1 H), 7.19
(dt, J = 4.6, 3.7 Hz, 2 H), 7.00 (dd, J = 5.9, 3.4 Hz, 1 H), 3.20 (t,
J = 6.9 Hz, 2 H), 3.13 (dt, J = 13.8, 6.9 Hz, 1 H), 2.33 (t, J = 7.4 Hz,
1 H), 1.67 (m, 1 H), 1.60 (m, 1 H), 1.44 (m, 1 H), 1.23 (t, J = 8.5 Hz,
3 H).
2.2. Instruments
A NanoDrop2000c spectrophotometer (Thermo Fisher, Shanghai,
China) was used to perform a UV–vis spectral scan to measure the
protein concentration. The plates used in the study were washed using a
Wellwasch™ microplate washer (Thermo Fisher, Hudson, NH, USA).
Other equipment included a MK3 microplate reader (Thermo Fisher,
Shanghai, China) and a DY6510 membrane strip reader (Wanlian Bio-
technologies Co. Ltd., Guangzhou, China).
2.3.5. Hapten-E, 2-(2-isopropylphenoxy)acetic acid
2.3. Hapten synthesis
The same synthesis procedure was used for hapten-E as for hapten-B,
except benzofuranol was replaced by 2-isopropylphenol. The following
results were obtained from the ESI-MS analysis (negative): m/z 193 [M-
H]-; 1H NMR (600 MHz, DMSO) δ 7.20 (dd, J = 7.5, 1.5 Hz, 1 H), 7.11
(m, 1 H), 6.91 (t, J = 7.4 Hz, 1 H), 6.81 (d, J = 8.2 Hz, 1 H), 4.68 (s,
2 H), 3.32 (dt, J = 13.9, 7.0 Hz, 1 H), 1.18 (d, J = 6.9 Hz, 6 H).
The uniform synthetic routes for the carbamate haptens are shown in
Fig. 1. The mass and NMR spectrograms used for sample characteriza-
tion are shown in the Supporting Material (Figs. S2–S9).
2.3.1. Hapten-A, 6-((((2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)oxy)
carbonyl)amino) hexanoic acid
2.3.6. Hapten-F, 4-(2-isopropylphenoxy)butanoic acid
Benzofuranol (3.2 g, 20 mmol) was dissolved in 15 mL of DCM with
5 mL of TEA and stirred in an ice bath at 0 ◦C. Five milliliters of DCM
containing 4 g (20 mmol) of 4-nitrophenyl chloroformate were added
dropwise to the benzofuranol solution, and the reaction was allowed to
proceed overnight under stirring at room temperature. After the reaction
was completed, DCM was removed by evaporation; TEA was then
removed by dissolving the residue in ethyl acetate, followed by washing
three times with 0.5 M HCl. The organic phase was evaporated to
remove ethyl acetate. The residue was dissolved in 5 mL of 1,4-dioxane
and then added to a 6-aminocaproic acid solution (5 g, dissolved in
15 mL of saturated sodium carbonate solution), and the mixture was
maintained under stirring overnight. The crude intermediate product
was filtered, and HCl was added to adjust the pH of the mixture to 3–4.
The mixture was evaporated to remove water and purified. The
following results were obtained from the ESI-MS analysis (negative): m/
z 320 [M-H]-; 1H NMR (600 MHz, DMSO) δ 12.02 (s, 1 H), 7.68 (t,
The same synthesis procedure was used for hapten-F as for hapten-C,
except that benzofuranol was replaced by 2-isopropylphenol. The
following results were obtained from the ESI-MS analysis (negative): m/
z 221 [M-H]-; 1H NMR (600 MHz, DMSO) δ 12.13 (s, 1 H), 7.14 (m, 2 H),
6.88 (dd, J = 14.2, 7.6 Hz, 2 H), 3.97 (t, J = 6.2 Hz, 2 H), 3.24 (dt,
J = 13.8, 6.9 Hz, 1 H), 2.42 (t, J = 7.3 Hz, 2 H), 1.97 (p, J = 6.5 Hz,
2 H), 1.15 (dd, J = 8.8, 4.5 Hz, 6 H).
2.3.7. Hapten-G, 6-(((naphthalen-1-yloxy)carbonyl)amino)hexanoic acid
The same synthesis procedure was used for hapten-H as for hapten-A,
except benzofuranol was replaced by 1-naphthol. The following results
were obtained from the ESI-MS analysis (negative): m/z 300 [M-H]-; 1H
NMR (600 MHz, acetone) δ 10.47 (s, 1 H), 8.01 (dd, J = 5.6, 4.1 Hz,
1 H), 7.94 (m, 1 H), 7.77 (d, J = 8.3 Hz, 1 H), 7.54 (m, 2 H), 7.49 (t,
J = 7.9 Hz, 1 H), 7.32 (m, 1 H), 7.04 (dd, J = 10.8, 3.8 Hz, 1 H), 3.30
3